Taking on Title X
Newsweek US|January 06 - 13, 2023 (Double Issue)
Does a ruling by a Trump-nominated judge signal a new assault on the right to contraception?
EWAN PALMER
Taking on Title X

ABORTION RIGHTS GROUPS HAVE RAISED concerns that a Donald Trump-nominated federal judge approving an anti-contraception lawsuit is proof the GOP will go further restricting the procedure post Roe v. Wade.

Matthew Kacsmaryk, a judge on the United States District Court for the Northern District of Texas, recently issued a ruling in the case of Deanda v. Becerra, a lawsuit filed by a Christian father hoping to block the Title X federal program.

In his suit, Alexander Deanda argues that Title X, which makes federally funded family planning services available to anyone, including minors, violates his constitutional rights as a parent.

Deanda claims that as he is raising his children as Christians and they therefore should "practice abstinence and refrain from sexual intercourse until marriage," Title X interferes with the upbringing of his children. 

While the judge, who was nominated to the bench by Trump in 2017, did not halt the program, he allowed both sides to present their arguments for what should happen next. Deanda's legal team have already signaled they will seek to temporarily shut down Title X while the case is being resolved, potentially putting young people's chance to access contraceptives in limbo while the case is being argued.

The opinion makes Kacsmaryk the first federal judge to approve a challenge to the right to contraception in the wake of the overturning of Roe v. Wade. Abortion rights and pro-contraception groups say the ruling is proof that fears conservative judges will use the Supreme Court's overturning of the landmark abortion ruling to push forward with further restrictions are coming to fruition.

Esta historia es de la edición January 06 - 13, 2023 (Double Issue) de Newsweek US.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición January 06 - 13, 2023 (Double Issue) de Newsweek US.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE NEWSWEEK USVer todo
AMERICA'S BEST LOYALTY PROGRAMS 2025
Newsweek US

AMERICA'S BEST LOYALTY PROGRAMS 2025

LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

time-read
3 minutos  |
February 21, 2025
Winning the Global Game
Newsweek US

Winning the Global Game

The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand

time-read
3 minutos  |
February 21, 2025
Solar Power
Newsweek US

Solar Power

Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality

time-read
2 minutos  |
February 21, 2025
Trump vs. Deep State
Newsweek US

Trump vs. Deep State

The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact

time-read
6 minutos  |
February 21, 2025
MAD ABOUT THE GIRL
Newsweek US

MAD ABOUT THE GIRL

AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER

time-read
10+ minutos  |
February 21, 2025
Armed and Dangerous
Newsweek US

Armed and Dangerous

A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies

time-read
4 minutos  |
February 21, 2025
Patrick Gibson
Newsweek US

Patrick Gibson

WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.

time-read
2 minutos  |
February 21, 2025
The AI Will See You Now
Newsweek US

The AI Will See You Now

A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care

time-read
6 minutos  |
February 21, 2025
Jasmin Savoy Brown
Newsweek US

Jasmin Savoy Brown

SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.

time-read
2 minutos  |
February 21, 2025
BIOTECH: Blood, Sweat and Tears
Newsweek US

BIOTECH: Blood, Sweat and Tears

Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't

time-read
6 minutos  |
February 14, 2025